Goal attainment following upper-limb botulinum toxin-A injections: are we facilitating achievement of client-centred goals?
Goal setting and review provides a clinically useful process for measuring upper-limb botulinum toxin-A outcomes.
The use of PSAV as a biopsy indicator would miss a large number of clinically significant PCa cases with increasing PSAV cut-offs. In this study, PSAV was not an independent predictor of a positive biopsy in general or significant PCa on biopsy. Therefore, PSAV does not improve the ERSPC screening algorithm.